v3.25.4
Business Segments and Geographic Information - Business Segment Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Segment Information      
Net sales $ 24,948 $ 24,575 $ 24,610
Selling, general and administrative expenses 3,997 4,221 19,198
Research, development and related expenses 1,169 1,085 1,154
Operating income (loss) 4,629 4,822 (10,689)
Gain (loss) on business divestitures [1] (162) 0 36
Total operating expenses (20,319) (19,753) (35,299)
Other expense (income), net 416 3 582
Income (loss) from continuing operations before income taxes 4,213 4,819 (11,271)
Depreciation and amortization 1,308 1,224 1,433
Capital expenditures 910 1,104 1,388
All other current assets 2,823 771  
Total assets 37,733 39,868
Operating Segments      
Business Segment Information      
Net sales 24,576 24,272 24,483
Operating income (loss) 5,268 5,001 4,540
Inventories 3,423 3,497 3,750
All other current assets 12,964 12,387
Total non-current assets 21,346 23,984
Operating Segments | Safety and Industrial      
Business Segment Information      
Net sales 11,384 10,961 10,956
Cost of sales 6,172 5,965 6,137
Selling, general and administrative expenses 1,858 2,020 2,023
Research, development and related expenses 518 485 472
Operating income (loss) 2,836 2,491 2,324
Depreciation and amortization 569 556 530
Capital expenditures 347 373 285
Inventories 1,636 1,509 1,592
Operating Segments | Transportation and Electronics      
Business Segment Information      
Net sales 8,272 8,380 8,501
Cost of sales 5,270 5,106 5,524
Selling, general and administrative expenses 1,080 1,236 1,207
Research, development and related expenses 486 460 458
Operating income (loss) 1,436 1,578 1,312
Depreciation and amortization 572 458 537
Capital expenditures 300 468 723
Inventories 1,093 1,269 1,459
Operating Segments | Consumer      
Business Segment Information      
Net sales 4,920 4,931 5,026
Cost of sales 2,941 2,912 3,064
Selling, general and administrative expenses 855 955 933
Research, development and related expenses 128 132 125
Operating income (loss) 996 932 904
Depreciation and amortization 155 157 160
Capital expenditures 61 80 105
Inventories 694 719 699
Corporate and Other      
Business Segment Information      
Net sales 372 303 127
Corporate-level (expense) income 75 (114) (485)
Net costs for significant litigation (483) (45) (14,785)
Divestiture costs 0 (20) (13)
Gain (loss) on business divestitures (162) 0 36
Russia exit (charges) benefits 0 0 18
Transformation costs (69) 0 0
Total operating expenses (639) (179) (15,229)
Depreciation and amortization 12 53 206
Capital expenditures $ 202 $ 183 $ 275
[1] The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.